Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G D LaVeck

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The Journal of Pediatrics|November 1, 1977
Sex differences in development among young children with Down syndromeB LaVeck, G D LaVeck
Infection and Immunity|May 1, 1983
Purification and characterization of a Shigella dysenteriae 1-like toxin produced by Escherichia coliA D O'Brien, G D LaVeck
The American Journal of Psychiatry|May 1, 1972
Mental retardation: development of an international classification schemeM J Begab, G D LaVeck
Infection and Immunity|March 1, 1982
Immunochemical and cytotoxic activities of Shigella dysenteriae 1 (shiga) and shiga-like toxinsA D O'Brien, G D Laveck
The West Virginia Medical Journal|May 1, 1970
Mental retardation: a challenge to physiciansF F De la Cruz, G D LaVeck
The Journal of Pediatrics|May 1, 1980
Minor congenital anomalies and behavior in different home environmentsB LaVeck, M A Hammond, G D LaVeck
Journal of Pediatric Psychology|June 1, 1983
Further observations on minor anomalies and behavior in different home environmentsB LaVeck, M A Hammond, R Telzrow, et al.
The Journal of Infectious Diseases|December 1, 1982
Production of Shigella dysenteriae type 1-like cytotoxin by Escherichia coliA D O'Brien, G D LaVeck, M R Thompson, et al.
Ecotoxicology and Environmental Safety|February 1, 1988
Validation of CHEMEST, an on-line system for the estimation of chemical propertiesR S Boethling, S E Campbell, D G Lynch, et al.
Infection and Immunity|October 1, 1980
Characterization of Shigella dysenteriae 1 (Shiga) toxin purified by anti-Shiga toxin affinity chromatographyA D O'Brien, G D LaVeck, D E Griffin, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Journal of Pediatrics|November 1, 1977
Sex differences in development among young children with Down syndromeB LaVeck, G D LaVeck
Infection and Immunity|May 1, 1983
Purification and characterization of a Shigella dysenteriae 1-like toxin produced by Escherichia coliA D O'Brien, G D LaVeck
The American Journal of Psychiatry|May 1, 1972
Mental retardation: development of an international classification schemeM J Begab, G D LaVeck
Infection and Immunity|March 1, 1982
Immunochemical and cytotoxic activities of Shigella dysenteriae 1 (shiga) and shiga-like toxinsA D O'Brien, G D Laveck
The West Virginia Medical Journal|May 1, 1970
Mental retardation: a challenge to physiciansF F De la Cruz, G D LaVeck
The Journal of Pediatrics|May 1, 1980
Minor congenital anomalies and behavior in different home environmentsB LaVeck, M A Hammond, G D LaVeck
Journal of Pediatric Psychology|June 1, 1983
Further observations on minor anomalies and behavior in different home environmentsB LaVeck, M A Hammond, R Telzrow, et al.
The Journal of Infectious Diseases|December 1, 1982
Production of Shigella dysenteriae type 1-like cytotoxin by Escherichia coliA D O'Brien, G D LaVeck, M R Thompson, et al.
Ecotoxicology and Environmental Safety|February 1, 1988
Validation of CHEMEST, an on-line system for the estimation of chemical propertiesR S Boethling, S E Campbell, D G Lynch, et al.
Infection and Immunity|October 1, 1980
Characterization of Shigella dysenteriae 1 (Shiga) toxin purified by anti-Shiga toxin affinity chromatographyA D O'Brien, G D LaVeck, D E Griffin, et al.
Pageof 2